Trials / Completed
CompletedNCT05661604
A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness
Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to describe the rate of occurrence of clinical diagnosis of acute respiratory infection (an infection that affects normal breathing) and different types of respiratory pathogens (harmful organisms) of new respiratory infections in a population at high risk for severe illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention | This is an observational study to assess the incidence and key disease characteristics of symptomatic acute respiratory viral infections in a high-risk population at risk for poor outcomes. Duration of each participant will be up to 12 months. |
Timeline
- Start date
- 2023-01-19
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
- First posted
- 2022-12-22
- Last updated
- 2025-02-28
Locations
4 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT05661604. Inclusion in this directory is not an endorsement.